Scarica l'app Stockscreener
20.61
2.64%
0.53
Instil Bio Inc Borsa (TIL) Ultime notizie
Long Term Trading Analysis for (TIL) - Stock Traders Daily
Trend Tracker for (TIL) - Stock Traders Daily
Instil Bio’s Strategic Shift To SYN-2510: A Speculative ‘Buy’ Opportunity (NASDAQ:TIL) - Seeking Alpha
How To Trade (TIL) - Stock Traders Daily
(TIL) Trading Report - Stock Traders Daily
Instil Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times
Instil Bio Secures Global Rights to PD-L1xVEGF Drug, Reports $122.9M Cash Position | TIL Stock News - StockTitan
2 Stocks Up Over 700% in 2024 That Could Soar Even Further - AOL
(TIL) Technical Data - Stock Traders Daily
JMP Securities initiates Instil Bio shares at Market Perform on public offering - Investing.com Australia
Instil Bio, Inc.'s (NASDAQ:TIL) stock price dropped 18% last week; private equity firms would not be happy - Simply Wall St
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising? - The Motley Fool
Analysis of Curative Ventures V LLC's Strategic Reduction in Instil Bio Inc - Yahoo Finance
(TIL) Long Term Investment Analysis - Stock Traders Daily
Baird maintains price target on Instil Bio stock, stays upbeat - Investing.com
5 Top NASDAQ Biotech Stocks of 2024 - Nasdaq
FDA Oncology Approvals Accelerate as Global Cancer Rates Set to Climb 77% - Baystreet.ca
Instil Bio Stock Skyrockets 641% in One Week: Here's Why - MSN
BOXER CAPITAL, LLC Acquires New Stake in Instil Bio Inc - GuruFocus.com
Perceptive Advisors LLC Acquires New Stake in Instil Bio Inc - GuruFocus.com
Baird sees Instil Bio stock upside on promising SYN-2510 clinical data - Investing.com
Fantastic Fest 2024: Clowns Rule at Texas’ No-Joke Genre Event Set to Debut ‘Terrifier 3,’ ‘V/H/S Beyond,’ and More - IndieWire
B. Riley Analysts Decrease Earnings Estimates for Inspired Entertainment, Inc. (NASDAQ:INSE) - Defense World
The time has not yet come to remove your chips from the table: Instil Bio Inc (TIL) - SETE News
Financial Metrics Unveiled: Instil Bio Inc (TIL)’s Key Ratios in the Spotlight - The Dwinnex
Instil Bio (TIL) Stock Rises In Extended Session On Major Strategy Reveal - Stocks Telegraph
Inspired Entertainment, Inc. to Post Q3 2024 Earnings of $0.22 Per Share, B. Riley Forecasts (NASDAQ:INSE) - Defense World
Ice Nine Kills to Release Official Song for Slasher Film Terrifier 3 - MetalSucks
Baird retains price target, outperform rating on Instil Bio shares By Investing.com - Investing.com Australia
Ice Nine Kills are releasing a new single for Terrifier 3 - Kerrang!
Ice Nine Kills’ Upcoming Single “A Work of Art” to Feature on "Terrifier 3" Soundtrack - Ghost Cult Magazine
Here's Why Everyone's Talking About Summit Therapeutics - MSN
This is why everyone is talking about Summit TherapeuticsTHE BHARAT EXPRESS NEWS - The Bharat Express News
Instil Bio stock target raised by H.C. Wainwright on cancer drug outlook - Investing.com
instilbiocorppres2024091.htm - SEC.gov
ICE NINE KILLS announce new 'TERRIFIER'-themed single and video starring SHAVO ODADJIAN - Revolver Magazine
Official 'Terrifier 3' Music Video from Ice Nine Kills Slashing into Fantastic Fest & AMC Theatres! - Bloody Disgusting
Crude Oil Surges Over 1%; Instil Bio Shares Plunge - MSN
Baird retains price target, outperform rating on Instil Bio shares - Investing.com India
Instil Bio Inc (TIL) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Baird positive on Instil Bio’s SYN-2510 development strategy - TipRanks
Do investors need to be concerned about Instil Bio Inc (TIL)? - US Post News
Instil Bio Outlines Oncology Strategy and Collaborative Efforts - TipRanks
Instil Bio price target raised to $120 from $40 at H.C. Wainwright - TipRanks
Instil Bio and ImmuneOnco Announce Global Registrational Strategy for PD-L1xVEGF Bispecific Antibody, SYN-2510/IMM2510, in Non-Small Cell Lung Cancer and Triple-Negative Breast Cancer - Yahoo Finance
iTeos Therapeutics, Upstart Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Up More Than 500% in 2024. Can Instil Bio Keep Rocketing Higher? - sharewise
Baird ups Instil Bio shares target as PD-1/L1xVEGF space gains momentum - Investing.com India
Summit lifts Instil, BioNTech on Merck beating data (NASDAQ:SMMT) - Seeking Alpha
Instil Bio: PD-L1/VEGF Bispecific Targeting With Unique Enhancements (TIL) - Seeking Alpha
Instil Bio surges after Baird target calls for shares tripling - TipRanks
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):